|
Volumn 18, Issue 2, 2004, Pages 338-340
|
Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID;
INDOLE DERIVATIVE;
PLATELET DERIVED GROWTH FACTOR;
PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;
PYRROLE DERIVATIVE;
SEMAXANIB;
VASCULOTROPIN A;
VASCULOTROPIN RECEPTOR 2;
ANIMAL;
ANOXIA;
APOPTOSIS;
ARTICLE;
BIOLOGICAL MODEL;
CELL SURVIVAL;
CYTOLOGY;
DRUG ANTAGONISM;
DRUG EFFECT;
METABOLISM;
MICROCIRCULATION;
NEOPLASM;
NEOVASCULARIZATION (PATHOLOGY);
PERICYTE;
SIGNAL TRANSDUCTION;
VASCULARIZATION;
ANIMALS;
ANOXIA;
APOPTOSIS;
CELL SURVIVAL;
INDOLES;
MICROCIRCULATION;
MODELS, BIOLOGICAL;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
PERICYTES;
PLATELET-DERIVED GROWTH FACTOR;
PYRROLES;
RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA;
SIGNAL TRANSDUCTION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;
MLCS;
MLOWN;
|
EID: 1442290142
PISSN: None
EISSN: 15306860
Source Type: Journal
DOI: 10.1096/fj.03-0271fje Document Type: Article |
Times cited : (546)
|
References (0)
|